Contact your GP if side effects significantly impact your quality of life
A wellness epidemic begins
Martinez, R., et al
semaglutide 2.4 mg suppressed appetite, improved control of eating, reduced the frequency and strength of food cravings, lowered ad libitum energy intake and was associated with clinically meaningful reductions in body weight versus placebo at week 20, with no evidence of delayed gastric emptying as measured indirectly through paracetamol absorption
Each compound clears a different bottleneck at the same dermal target: Collagen quality and firmness GHK-Cu activates collagen-gene transcription and supplies the copper cofactor for cross-linking Microvascular delivery BPC-157 builds the capillary network that feeds active tissue Organized tissue, scar remodeling full-length TB-4 mobilizes repair cells with anti-scarring bias Inflammation control KPV pre-empts NF-B-driven flushing, redness, and reactive flares Practical readouts: hydration and texture by 24 weeks, fine lines softening by 48, firmer structure and scar remodeling by 812
Reviews in endocrine & metabolic disorders, 15(3), 181187.
